Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Sunshine Biopharma (SBFM) over the last 5 years, with Dec 2024 value amounting to $2.0 million.

  • Sunshine Biopharma's Shares Outstanding (Weighted Average) rose 272.11% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 272.11%. This contributed to the annual value of $2.0 million for FY2024, which is 15474.89% up from last year.
  • Per Sunshine Biopharma's latest filing, its Shares Outstanding (Weighted Average) stood at $2.0 million for FY2024, which was up 15,474.89% from $12,839 recorded in FY2023.
  • Sunshine Biopharma's Shares Outstanding (Weighted Average)'s 5-year high stood at $2.0 million during FY2024, with a 5-year trough of $1,163 in FY2020.
  • Over the past 3 years, Sunshine Biopharma's median Shares Outstanding (Weighted Average) value was $12,839 (recorded in 2023), while the average stood at $674,597.
  • Data for Sunshine Biopharma's Shares Outstanding (Weighted Average) shows a peak YoY soared of 15,474.89% (in 2024) over the last 5 years.
  • Over the past 5 years, Sunshine Biopharma's Shares Outstanding (Weighted Average) (Yearly) stood at $1,163 in 2020, then grew by 10.75% to $1,288 in 2021, then surged by 776.79% to $11,293 in 2022, then grew by 13.69% to $12,839 in 2023, then soared by 15,474.89% to $2.0 million in 2024.